Delivery Order SPE2DB22D3501-SPE2DB26FTK68
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency (DLA) on November 4, 2025, for TIBSOVO 250 mg tablets (60-count supply) with a firm fixed price ceiling value of $21,827.41. The contract is scheduled for completion by November 26, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a $21,827.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg on August 7, 2025, with completion scheduled for August 28, 2025. This non-set-aside award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $21.8K delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Tibsovo (ivosidenib) 250 mg tablets in a quantity of 60 units. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The contract is set to be completed by December 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of TIBSOVO 250 mg, a pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $21,827.40, was competitively awarded without set-aside provisions and is scheduled for completion by May 14, 2025. The order was placed on April 23, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 28, 2025, by the Defense Logistics Agency to supply 60 tablets of Tibsovo 250 mg, a prescription medication used in oncology treatment. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $43,654.80 and is scheduled for completion by October 20, 2025. The contract contains no set-aside designation and...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $19,882.84 firm fixed price delivery order is for the supply of TIBSOVO 250 MG tablets. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIBSOVO 250 MG TABLET 60S, a prescription medication, with a total ceiling value of $21,827.40 and a period of performance through July 22, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $19,882.84 fixed-price delivery order is for the supply of the prescription medication Tibsovo (ivosidenib) 250 mg tablets. This contract is not set aside for any particular business size or type. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency Troop Support Medical awarded a $19,482 delivery order to Amerisourcebergen Drug Corp Corporate Office Division for 250 mg tablets of TIBSOVO. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 60 tablets of the specified medication to a location in Conshohocken, Pennsylvania, with performance required between July 10-31, 2023. No additional details were provided regarding major subcontractors or a potential set-aside designation. The...
- The Defense Logistics Agency awarded a delivery order valued at $15,714.54 to AmerisourceBergen Drug Corp for ITOVEBI 3 MG tablets (28-count supply) on September 22, 2025, with an ultimate completion date of October 14, 2025. This firm fixed price contract was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single fulfillment under AmerisourceBergen's larger...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB26FTK68Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $21,827.41 to AmerisourceBergen Drug Corp for TIBSOVO 250 mg tablets (60-count units) on November 6, 2025, with completion scheduled for December 1, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order exemplifies AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain, particularly supporting military healthcare systems and the Defense Health Agency. TIBSOVO (ivosidenib) is a specialized oncology medication, consistent with AmerisourceBergen's portfolio of brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. As a major healthcare solutions provider, AmerisourceBergen has demonstrated its capability to fulfill federal procurement requirements through open competition and maintains significant contract relationships with DLA to support global military healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.8k | 11/6/25 |